| 0050139 | C-1-Esterase Inhibitor Panel
|
| 2002068 | c ANCA (Anti-Neutrophil Cytoplasmic Antibody with Reflex to Titer & MPO/PR-3 Antibodies) |
| 2007933 | C Antigen Typing - Patient
|
| 2003806 | C-Kit (CD117 (c-Kit) by Immunohistochemistry) |
| 2002674 | c-KIT (Gastrointestinal Stromal Tumor Mutation) |
| 2002695 | c-KIT (KIT Mutations, Melanoma)
|
| 0081121 | C-Peptide, 24-Hour Urine
|
| 0070103 | C-Peptide, Serum or Plasma
|
| 0050180 | C-Reactive Protein
|
| 0050182 | C-Reactive Protein, High Sensitivity
|
| 0050181 | C-Reactive Protein, Neonatal
|
| 0070416 | C-Telopeptide, Beta-Cross-Linked, Serum
|
| 0080380 | C, Vitamin (Vitamin C, Plasma) |
| 2002674 | c-kit Mutation Analysis in Gastrointestinal Stromal Tumors (GISTs) (Gastrointestinal Stromal Tumor Mutation)
|
| 2002298 | C-Myc (MYC) Rearrangement (Chromosome FISH, Interphase)
|
| 0099078 | C1 (Complement Component 1, Functional) |
| 0050140 | C1-Esterase Inhibitor
|
| 0050140 | C1 Esterase Inhibitor Antigen, Serum (C1-Esterase Inhibitor) |
| 0050141 | C1-Esterase Inhibitor Functional
|
| 0050141 | C1 Inactivator (C1-Esterase Inhibitor Functional) |
| 0050140 | C1 Inactivator, Quantitative (C1-Esterase Inhibitor) |
| 0050140 | C1 Inhibitor (C1INH) (C1-Esterase Inhibitor) |
| 0050301 | C1q Binding Assay
|
| 0099130 | C1q Level (Complement Component 1q Level) |
| 0050148 | C2 (Complement Component 2) |
| 0050149 | C3 & C4 (Complement Components 3 & 4) |
| 0050150 | C3 (Complement Component 3) |
| 2003304 | C3A (Complement Component 3A) |
| 2003475 | C4D by Immunohistochemistry
|
| 0050156 | C5 (Complement Component 5) |
| 2001510 | C5-DC Acylcarnitine (Glutarylcarnitine Quantitative, Urine) |
| 0099072 | C6 Complement Component Level (Complement Component 6) |
| 0099121 | C7 (Complement Component 7 Functional) |
| 0099133 | C8 (Complement Component 8 Functional) |
| 0020408 | C12 (Comprehensive Metabolic Panel) |
| 2008097 | C1q Functional
|
| 0050302 | C3d Circulating Immune Complexes (Raji Cell Immune Complex Assay) |
| 0050155 | C4 (Complement Component 4) |
| 0080462 | CA 125 (Cancer Antigen 125) |
| 0080464 | CA 15-3 (Cancer Antigen-Breast (CA 15-3)) |
| 0080461 | CA 19-9 (Cancer Antigen-GI (CA 19-9)) |
| 0020746 | CA 19-9 (Cancer Antigen-GI (CA 19-9), Body Fluid) |
| 0080392 | CA 27.29 (Cancer Antigen 27.29) |
| 0080464 | CA-Breast (Cancer Antigen-Breast (CA 15-3)) |
| 0080461 | CA-GI (Cancer Antigen-GI (CA 19-9)) |
| 2003869 | Cadherin (E-Cadherin by Immunohistochemistry) |
| 0099675 | Cadmium, Blood
|
| 0020584 | Cadmium (Cd) (Heavy Metals Panel 4, Blood) |
| 0020572 | Cadmium (Cd) (Heavy Metals Panel 4, Urine with Reflex to Arsenic Fractionated) |
| 0025055 | Cadmium (Cd) (Heavy Metals Panel 6, Urine with Reflex to Arsenic Fractionated) |
| 0025013 | Cadmium Exposure Panel - OSHA
|
| 0025040 | Cadmium, Urine
|
| 0090050 | Caffeine
|
| 0090050 | Caffeine Citrate Injection (Caffeine) |
| 0092330 | CAH (Adrenal Steroid Quantitative Panel by LC-MS/MS, Serum or Plasma) |
| 0091429 | Calan® (Verapamil, Serum or Plasma)
|
| 2002348 | Calcidiol (25-Hydroxyvitamin D2 and D3 by Tandem Mass Spectrometry, Serum)
|
| 0070006 | Calcitonin
|
| 2003481 | Calcitonin by Immunohistochemistry
|
| 0080385 | Calcitriol (Vitamin D, 1, 25-Dihydroxy) |
| 0020135 | Calcium, Ionized, Serum
|
| 0020140 | Calcium, Ionized, Whole Blood
|
| 0020027 | Calcium, Serum or Plasma
|
| 0020472 | Calcium, Urine
|
| 2004589 | Calcofluor Stain (Fungal Stain, KOH with Calcofluor White) |
| 0099460 | Calculi (Stone) Analysis
|
| 2005231 | Calculi (Stone) Analysis with Photo
|
| 2003484 | Caldesmon by Immunohistochemistry
|
| 0092211 | Calepsin (Carbamazepine Epoxide and Total) |
| 0090615 | Calepsin (Carbamazepine, Free and Total) |
| 0098893 | California Encephalitis Antibody, IgG by IFA, CSF
|
| 0050508 | California Encephalitis Antibody, IgG by IFA, Serum
|
| 0098898 | California Encephalitis Antibody, IgM by IFA, CSF
|
| 0098731 | California Encephalitis Antibody, IgM by IFA, Serum
|
| 2003523 | CALLA (CD10 (CALLA) by Immunohistochemistry) |
| 2003487 | Calponin by Immunohistochemistry
|
| 0092303 | Calprotectin, Fecal
|
| 2003490 | Calretinin by Immunohistochemistry
|
| 2003493 | CAM 5.2 LMW (Cytokeratin 8,18 Low Molecular Weight (CAM 5.2) by Immunohistochemistry) |
| 0050994 | Camplyobacter (Helicobacter pylori Antibodies, IgG & IgA)
|
| 0050995 | Camplyobacter (Helicobacter pylori Antibody, IgA)
|
| 0099359 | Camplyobacter (Helicobacter pylori Antibody, IgG)
|
| 0098392 | Camplyobacter (Helicobacter pylori Antibody, IgM)
|
| 0058002 | Campylobacter Antigen
|
| 0060135 | Campylobacter Culture (Stool Culture, Campylobacter)
|
| 0098841 | Campylobacter jejuni Antibody, IgG
|
| 0095505 | Canale-Smith Syndrome (Autoimmune Lymphoproliferative Profile) |
| 0051415 | Canavan (Ashkenazi Jewish Diseases (BLM, ASPA, IKBKAP, FANCC, GBA, MCOLN1, SMPD1, HEXA))
|
| 0051454 | Canavan (ASPA) 4 Mutations, Fetal
|
| 0051453 | Canavan Disease (ASPA) 4 Mutations
|
| 0080392 | Cancer Antigen 27.29
|
| 0080462 | Cancer Antigen 125
|
| 2003478 | Cancer Antigen 125 by Immunohistochemistry
|
| 0080464 | Cancer Antigen-Breast (CA 15-3)
|
| 0080461 | Cancer Antigen-GI (CA 19-9)
|
| 0020746 | Cancer Antigen-GI (CA 19-9), Body Fluid
|
| 0095200 | Candida albicans Antibodies IgA, IgG, and IgM by ELISA
|
| 0055565 | Candida Antibody by ID
|
| 0095200 | Candida IgG, IgM, IgA Ab Panel (Candida albicans Antibodies, IgA, IgG, & IgM by ELISA)
|
| 0065153 | Candida Species (Vaginal Pathogens DNA Direct Probes)
|
| 0090676 | Cannabinoids (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (9-carboxy-THC) - Serum or Plasma)
|
| 0090369 | Cannabinoids (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (9-carboxy-THC) - Urine) |
| 0092316 | Cannabinoids (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (Marijuana) - Meconium) |
| 2008091 | CANNABINOMIMETICS
|
| 0090676 | Cannabis (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (9-carboxy-THC) - Serum or Plasma) |
| 0090369 | Cannabis (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (9-carboxy-THC) - Urine) |
| 0092316 | Cannabis (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (Marijuana) - Meconium) |
| 0091339 | Canrenone, Serum or Plasma
|
| 0092524 | Capadex (Drugs of Abuse Confirmation/Quantitation - Propoxyphene & Metabolite - Meconium) |
| 0091363 | Capadex (Drugs of Abuse Confirmation/Quantitation - Propoxyphene & Metabolite - Serum or Plasma) |
| 0090368 | Capadex (Drugs of Abuse Confirmation/Quantitation - Propoxyphene & Metabolite - Urine) |
| 2001999 | CaPDETECT:PCA3 (PCA3 - Prostate Cancer Biomarker)
|
| 2002730 | Capillary Malformation-Arteriovenous Malformation Syndrome (RASA1-Related Disorders (RASA1) Sequencing)
|
| 2001961 | Capillary Malformation-Arteriovenous Malformation Syndrome (RASA1) Sequencing (Familial Mutation, Targeted Sequencing)
|
| 2007852 | Capillary Malformation-Arteriovenous Malformation Syndrome (RASA1-Related Disorders (RASA1) Sequencing and Deletion/Duplication)
|
| 2007830 | Capillary Malformation-Arteriovenous Malformation Syndrome (RASA1-Related Disorders (RASA1) Sequencing)
|
| 0092211 | Carbamazepine - 10,11 Epoxide, Serum or Plasma (Carbamazepine Epoxide and Total) |
| 0091166 | Carbamazepine - 10,11 Epoxide, Urine
|
| 0092211 | Carbamazepine-10 (Carbamazepine Epoxide and Total) |
| 0092211 | Carbamazepine and Epoxide Metabolite (Carbamazepine Epoxide and Total) |
| 0092211 | Carbamazepine Epoxide and Total
|
| 0090615 | Carbamazepine, Free and Total
|
| 0090615 | Carbamazepine, Free (Carbamazepine, Free and Total) |
| 0090260 | Carbamazepine, Total
|
| 0090615 | Carbatrol (Carbamazepine, Free and Total) |
| 0091372 | Carbex (Drugs of Abuse Confirmation/Quantitation - Amphetamine - Serum or Plasma) |
| 0092310 | Carbex (Drugs of Abuse Confirmation/Quantitation - Amphetamines (Amphetamine & Methamphetamine) - Meconium)
|
| 0090439 | Carbex (Drugs of Abuse Confirmation/Quantitation - Amphetamines - Urine) |
| 0091352 | Carbidopa and Levodopa Quantitative, Serum or Plasma
|
| 0080461 | Carbohydrate Antigen (Cancer Antigen-GI (CA 19-9)) |
| 2002918 | Carbohydrate Deficient Glycoprotein Syndrome (Carbohydrate Deficient Transferrin for Congenital Disorders of Glycosylation)
|
| 0070412 | Carbohydrate Deficient Transferrin for Alcohol Use
|
| 2002918 | Carbohydrate Deficient Transferrin for Congenital Disorders of Glycosylation
|
| 0091260 | Carbolic Acid (Phenol Exposure, Urine) |
| 0020004 | Carbon Dioxide, Serum or Plasma
|
| 2005757 | Carbon monoxide |
| 0090676 | 9-Carboxy-THC (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (9-carboxy-THC) - Serum or Plasma)
|
| 0090369 | 9-Carboxy-THC (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (9-carboxy-THC) - Urine) |
| 0092316 | 9-Carboxy-THC (Drugs of Abuse Confirmation/Quantitation - Cannabinoids (Marijuana) - Meconium) |
| 2005757 | Carboxyhemoglobin Quantitation, Whole Blood by Co-Oximetry
|
| 0080080 | Carcinoembryonic Antigen
|
| 0020742 | Carcinoembryonic Antigen, Fluid
|
| 2003824 | Carcinoembryonic Antigen, Monoclonal (CEA M) by Immunohistochemistry
|
| 2003827 | Carcinoembryonic Antigen, Polyclonal (CEA P) by Immunohistochemistry
|
| 2002293 | cardiac defect |
| 2002291 | cardiac defect |
| 2002289 | cardiac defect |
| 2005763 | cardiac defect |
| 0051600 | Cardiolipin and Non-Criteria Anti-Phospholipid Syndrome (APS) Antibody Panel
|
| 0099344 | Cardiolipin Antibodies, IgG and IgM
|
| 0051162 | Cardiolipin Antibodies, IgG, IgM, and IgA
|
| 0098358 | Cardiolipin Antibody, IgA
|
| 0050901 | Cardiolipin Antibody, IgG
|
| 0050902 | Cardiolipin Antibody, IgM
|
| 0090245 | Cardioquin (Quinidine) |
| 0091348 | Cardizem® (Diltiazem, Serum or Plasma)
|
| 0090600 | Carisoprodol and Meprobamate
|
| 0090600 | Carisoprodol and Metabolite (Carisoprodol and Meprobamate) |
| 2007234 | Carisoprodol and Metabolite, Urine
|
| 0090500 | Carisoprodol Screen w/reflex Confirmation (Drug Screen (Nonforensic), Urine, Qualitative) |
| 2004199 | Carnitine Deficiency (Primary Carnitine Deficiency (SLC22A5) Deletion/Duplication)
|
| 0051682 | Carnitine Deficiency (Primary Carnitine Deficiency (SLC22A5) Sequencing)
|
| 2004203 | Carnitine Deficiency (Primary Carnitine Deficiency (SLC22A5) Sequencing and Deletion/Duplication)
|
| 2001961 | Carnitine Deficiency, Primary (SLC22A5) (Familial Mutation, Targeted Sequencing)
|
| 0080065 | Carnitine, Free
|
| 0080068 | Carnitine, Free & Total (Includes Carnitine, Esterified)
|
| 0081308 | Carnitine, Free & Total, Urine
|
| 0081309 | Carnitine, Free, Urine
|
| 0081110 | Carnitine Panel
|
| 0080067 | Carnitine, Total
|
| 0081307 | Carnitine, Total, Urine
|
| 0080512 | Carnitine Transport, Fibroblasts
|
| 0080055 | Carotene, Serum Total
|
| 0021021 | Carotenes, Fractionated, Plasma or Serum
|
| 2003496 | Caspase-3 by Immunohistochemistry
|
| 2003496 | Caspase-3 IHC with Interpretation (Caspase-3 by Immunohistochemistry) |
| 2003496 | Caspase-3 IHC without Interpretation (Caspase-3 by Immunohistochemistry) |
| 0093057 | Cat Scratch Disease (Bartonella DNA Detection by PCR)
|
| 0060762 | Cat Scratch Disease (Bartonella DNA Detection by PCR, Whole Blood)
|
| 0050091 | Cat Scratch Fever (Bartonella henselae Antibody, IgG by IFA)
|
| 0050092 | Cat Scratch Fever (Bartonella henselae Antibody, IgM by IFA)
|
| 0050108 | Cat Scratch Fever (Bartonella henselae (Cat Scratch) Antibodies, IgG & IgM by IFA)
|
| 0091362 | Catapres®Duraclon Kapvay ® (Clonidine, Serum or Plasma)
|
| 0091223 | Catapres® Duraclon Kapvay ® (Clonidine, Urine)
|
| 0080216 | Catecholamine Fractionation (Catecholamines Fractionated, Plasma) |
| 2006224 | Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) Panel, 3 Genes
|
| 0080407 | Catecholamines Fractionated by LC-MS/MS, Urine Free
|
| 0080957 | Catecholamines Fractionated (Epinephrine, Norepinephrine), Plasma
|
| 0080216 | Catecholamines Fractionated, Plasma
|
| 0080216 | Catecholamines, Free (Catecholamines Fractionated, Plasma) |
| 0040002 | CBC with Platelet Count
|
| 0040003 | CBC with Platelet Count and Automated Differential
|
| 0092209 | CBFB-MYH1, inv(16) by RT-PCR
|
| 2002298 | CBFB Rearrangement (Chromosome FISH, Interphase)
|
| 2004247 | CCAAT Enhancer Binding Protein Alpha (CEBPA Mutation Detection)
|
| 2003499 | CCC9 (Complement Component C9 (CCC9) by Immunohistochemistry) |
| 2003172 | CCM1 (Cerebral Cavernous Malformation (CCM1, CCM2 and CCM3) Deletion/Duplication)
|
| 2003152 | CCM1 Sequencing (Cerebral Cavernous Malformation (CCM1) Sequencing)
|
| 2003172 | CCM2 (Cerebral Cavernous Malformation (CCM1, CCM2 and CCM3) Deletion/Duplication)
|
| 2003156 | CCM2 (Cerebral Cavernous Malformation (CCM2) Sequencing)
|
| 2003172 | CCM3 (Cerebral Cavernous Malformation (CCM1, CCM2 and CCM3) Deletion/Duplication)
|
| 2003160 | CCM3 (Cerebral Cavernous Malformation (CCM3) Sequencing)
|
| 2002298 | CCND1/IGH Fusion (Chromosome FISH, Interphase)
|
| 0055256 | CCP3 Antibody (Cyclic Citrullinated Peptide (CCP) Antibody, IgG) |
| 0093370 | CCR5, CXCR4, CR5 (Trofile Co-Receptor Tropism Assay) |
| 0099675 | Cd (Cadmium, Blood) |
| 2003502 | CD1a by Immunohistochemistry
|
| 2003505 | CD2 by Immunohistochemistry
|
| 2003508 | CD3 by Immunohistochemistry
|
| 2003511 | CD4 by Immunohistochemistry
|
| 2003514 | CD5 by Immunohistochemistry
|
| 2003517 | CD7 by Immunohistochemistry
|
| 2003520 | CD8 by Immunohistochemistry
|
| 2003523 | CD10 (CALLA) by Immunohistochemistry
|
| 2003526 | CD14 by Immunohistochemistry
|
| 2003529 | CD15, Leu M1 by Immunohistochemistry
|
| 2005114 | CD19 by Immunohistochemistry
|
| 2003532 | CD20, L26 by Immunohistochemistry
|
| 2003535 | CD21 (Dendritic Cell) by Immunohistochemistry
|
| 2003541 | CD23 by Immunohistochemistry
|
| 2003544 | CD25 by Immunohistochemistry
|
| 2003547 | CD30 (Ki-1) by Immunohistochemistry
|
| 2003550 | CD31 by Immunohistochemistry
|
| 2003553 | CD33 by Immunohistochemistry
|
| 2003556 | CD34, QBEnd/10 by Immunohistochemistry
|
| 2003559 | CD35 by Immunohistochemistry
|
| 0095854 | CD4 (Lymphocyte Subset Panel 1 - CD4 Absolute Count Only) |
| 0095885 | CD4 (Lymphocyte Subset Panel 2 - CD4 Percent & Absolute) |
| 2003565 | CD42b by Immunohistochemistry
|
| 2003568 | CD43, L60 (Leu 22) by Immunohistochemistry
|
| 2003571 | CD44 by Immunohistochemistry
|
| 2003574 | CD45 by Immunohistochemistry
|
| 2003586 | CD52 (CAMPATH-1) by Immunohistochemistry
|
| 2003589 | CD56 (NCAM) by Immunohistochemistry
|
| 2003592 | CD57 by Immunohistochemistry
|
| 2003595 | CD61 (Platelet Gycoprotein IIIA) by Immunohistochemistry
|
| 2003598 | CD68, KP1 by Immunohistochemistry
|
| 2003800 | CD79A by Immunohistochemistry
|
| 2004055 | CD99 (Ewing Sarcoma (O13) by Immunohistochemistry) |
| 2003806 | CD117 (c-Kit) by Immunohistochemistry
|
| 2002674 | CD117 (Gastrointestinal Stromal Tumor Mutation) |
| 2002695 | CD117 KIT (KIT Mutations, Melanoma)
|
| 2003809 | CD123 by Immunohistochemistry
|
| 2003812 | CD138 (Syndecan-1) by Immunohistochemistry
|
| 2008101 | CD154 |
| 2003815 | CD163 by Immunohistochemistry
|
| 0092099 | CD20 on B Cells (B-Cell CD20 Expression) |
| 2008112 | CD278 |
| 2008101 | CD40 Ligand (CD154) Expression
|
| 0099675 | CDB (Cadmium, Blood) |
| 2002918 | CDG (Carbohydrate Deficient Transferrin for Congenital Disorders of Glycosylation) |
| 2002918 | CDGS (Carbohydrate Deficient Transferrin for Congenital Disorders of Glycosylation) |
| 2005534 | CDK4 by Immunohistochemistry
|
| 2004927 | CDKL5-Related Disorders (CDKL5) Deletion/Duplication
|
| 2004931 | CDKL5-Related Disorders (CDKL5) Sequencing
|
| 2004935 | CDKL5-Related Disorders (CDKL5) Sequencing and Deletion/Duplication
|
| 2001961 | CDKL5-Related Disorders (CDKL5) Sequencing (Familial Mutation, Targeted Sequencing)
|
| 2001980 | CDKL5-Related Disorders (Familial Mutation, Targeted Sequencing, Fetal); |
| 0070412 | CDT (Carbohydrate Deficient Transferrin for Alcohol Use) |
| 2002918 | CDT (Carbohydrate Deficient Transferrin for Congenital Disorders of Glycosylation) |
| 0025040 | CDU (Cadmium, Urine) |
| 2003821 | CDX2 by Immunohistochemistry
|
| 2003821 | CDX2, IHC with Interpretation (CDX2 by Immunohistochemistry) |
| 2003821 | CDX2, IHC without Interpretation (CDX2 by Immunohistochemistry) |
| 0080080 | CEA (Carcinoembryonic Antigen) |
| 0020742 | CEA (Carcinoembryonic Antigen, Fluid) |
| 2002299 | CEB 108/T7/CDC2LC (p58) (Chromosome FISH, Metaphase) |
| 2004247 | CEBP Alpha (CEBPA Mutation Detection)
|
| 2004247 | CEBPA Mutation Analysis (CEBPA Mutation Detection) |
| 2004247 | CEBPA Mutation Detection
|
| 2003302 | Celexa® (Citalopram, Serum or Plasma)
|
| 0092382 | Celexa (Escitalopram, Serum or Plasma) |
| 0050734 | Celiac disease (Tissue Transglutaminase (tTG) Antibody, IgA with Reflex to Endomysial Antibody, IgA) |
| 0097709 | Celiac Disease (Tissue Transglutaminase Antibody (tTG), IgA) |
| 0051358 | Celiac Disease Antibodies (Deamidated Gliadin Peptide (DGP) Antibodies, IgA & IgG) |
| 0051357 | Celiac Disease Antibodies (Deamidated Gliadin Peptide (DGP) Antibody, IgA) |
| 0051359 | Celiac Disease Antibodies (Deamidated Gliadin Peptide (DGP) Antibody, IgG) |
| 0098878 | Celiac Disease (CD) Antibodies (Reticulin Antibody, IgG with Reflex to Titer) |
| 0051689 | Celiac Disease Dual Antigen Screen
|
| 2002026 | Celiac Disease Dual Antigen Screen with Reflex
|
| 2005018 | Celiac Disease (HLA-DQA1*05, HLA-DQB1*02, and HLA-DQB1*03:02) Genotyping
|
| 0051065 | Celiac Disease Reflexive Panel
|
| 0051065 | Celiac Sprue (Celiac Disease Reflexive Panel) |
| 0095019 | Cell Count, Body Fluid
|
| 0095018 | Cell Count, CSF
|
| 0051273 | Cell-Mediated Immune Function Screen
|
| 2007537 | cell-free, |
| 2007715 | Cellano Antigen Typing - Patient
|
| 0090213 | CellCept™ MPA (Mycophenolic Acid)
|
| 0090213 | Cellcept™ (Mycophenolic Acid)
|
| 2002173 | CellCept™ (Mycophenolic Acid and Metabolite, Serum)
|
| 2007537 | cellfree |
| 0060051 | Cellulose Tape Test (Pinworm) |
| 0090146 | Celontin (Methsuximide & Normethsuximide) |
| 2002756 | Centralgin (Meperidine & Metabolite - Confirmation/Quantitation - Serum or Plasma) |
| 2002760 | Centralgin (Meperidine & Metabolite - Confirmation/Quantitation - Urine) |
| 0092520 | Centrax (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Meconium) |
| 0093300 | Centrax (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Serum or Plasma) |
| 0090358 | Centrax (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Urine) |
| 0090672 | Centrax (Prazepam (Assayed as Nordiazepam)) |
| 0050714 | Centromere Antibody, IgG
|
| 0050714 | Centromere B (Centromere Antibody, IgG) |
| 0090045 | Cephadyn (Butalbital) |
| 0091180 | Cephaeline (Ipecac Use Markers, Serum or Plasma - Screen with Reflex to Confirmation/Quantitation) |
| 0050670 | Cerebrospinal Fluid, IgG (Immunoglobulin G, CSF) |
| 2003172 | Cerebral Cavernous Angioma (Cerebral Cavernous Malformation (CCM1, CCM2 and CCM3) Deletion/Duplication)
|
| 2003152 | Cerebral Cavernous Angioma (Cerebral Cavernous Malformation (CCM1) Sequencing)
|
| 2003164 | Cerebral Cavernous Angioma (Cerebral Cavernous Malformation (CCM1) Sequencing with Reflex to (CCM1, CCM2 and CCM3) Deletion/Duplication with Reflex to (CCM2) Sequencing with Reflex to (CCM3) Sequencing)
|
| 2003156 | Cerebral Cavernous Angioma (Cerebral Cavernous Malformation (CCM2) Sequencing)
|
| 2003160 | Cerebral Cavernous Angioma (Cerebral Cavernous Malformation (CCM3) Sequencing)
|
| 2007384 | 2003152 Cerebral Cavernous Malformation (CCM1) Sequencing
|
| 2007390 | 2003152 Cerebral Cavernous Malformation (CCM1) Sequencing
|
| 2007384 | 2003164 Cerebral Cavernous Malformation (CCM1) Sequencing with Reflex to (CCM1, CCM2 and CCM3) Delet
|
| 2007380 | 2003164 Cerebral Cavernous Malformation (CCM1) Sequencing with Reflex to (CCM1, CCM2 and CCM3) Delet |
| 2007390 | 2003164 Cerebral Cavernous Malformation (CCM1) Sequencing with Reflex to (CCM1, CCM2 and CCM3) Delet
|
| 2007390 | 2003172 Cerebral Cavernous Malformation (CCM1, CCM2, and CCM3) Deletion/Duplication
|
| 2007380 | 2003172 Cerebral Cavernous Malformation (CCM1, CCM2, and CCM3) Deletion/Duplication |
| 2007384 | 2003172 Cerebral Cavernous Malformation (CCM1, CCM2, and CCM3) Deletion/Duplication
|
| 2007384 | 2003156 Cerebral Cavernous Malformation (CCM2) Sequencing
|
| 2007390 | 2003156 Cerebral Cavernous Malformation (CCM2) Sequencing
|
| 2007380 | 2003156 Cerebral Cavernous Malformation (CCM2) Sequencing |
| 2007380 | 2003160 Cerebral Cavernous Malformation (CCM3) Sequencing |
| 2007390 | 2003160 Cerebral Cavernous Malformation (CCM3) Sequencing
|
| 2007384 | 2003160 Cerebral Cavernous Malformation (CCM3) Sequencing
|
| 2003172 | Cerebral Cavernous Malformation (CCM1, CCM2 and CCM3) Deletion/Duplication
|
| 2001961 | Cerebral Cavernous Malformation (CCM1) (Familial Mutation, Targeted Sequencing)
|
| 2003152 | Cerebral Cavernous Malformation (CCM1) Sequencing
|
| 2003164 | Cerebral Cavernous Malformation (CCM1) Sequencing with Reflex to (CCM1, CCM2 and CCM3) Deletion/Duplication with Reflex to (CCM2) Sequencing with Reflex to (CCM3) Sequencing
|
| 2001961 | Cerebral Cavernous Malformation (CCM2) (Familial Mutation, Targeted Sequencing)
|
| 2003156 | Cerebral Cavernous Malformation (CCM2) Sequencing
|
| 2001961 | Cerebral Cavernous Malformation (CCM3) (Familial Mutation, Targeted Sequencing)
|
| 2003160 | Cerebral Cavernous Malformation (CCM3) Sequencing
|
| 2003164 | Cerebral Cavernous Malformation (KRIT1) (Cerebral Cavernous Malformation (CCM1) Sequencing with Reflex to (CCM1, CCM2 and CCM3) Deletion/Duplication with Reflex to (CCM2) Sequencing with Reflex to (CCM3) Sequencing)
|
| 0060106 | Cerebrospinal Fluid (CSF) Culture and Gram Stain
|
| 8209703 | Cerebrospinal Fluid for Cytology (Cytology, Cerebrospinal Fluid) |
| 0092118 | Certican (Everolimus by Tandem Mass Spectrometry) |
| 0050160 | Ceruloplasmin
|
| 2005277 | Cervista™ HPV 16/18 (Human Papillomavirus (HPV), Genotypes 16 and 18)
|
| 2005277 | Cervista™ HPV High Risk (Human Papillomavirus (HPV), Genotypes 16 and 18)
|
| 2005283 | Cervista™ HPV High Risk (Human Papillomavirus (HPV), High Risk with Reflex to Genotypes 16 and 18)
|
| 2005283 | Cervista™ HPV 16/18 (Human Papillomavirus (HPV), High Risk with Reflex to Genotypes 16 and 18)
|
| 0040248 | Cetuximab (Erbitux) (KRAS Mutation Detection)
|
| 2001932 | Cetuximab (Erbitux) (KRAS Mutation Detection with Reflex to BRAF Codon 600 Mutation Detection)
|
| 2007537 | cffDNA |
| 0051642 | CFTR MLPA (Cystic Fibrosis (CFTR) Deletion/Duplication)
|
| 2003414 | CGH |
| 2004434 | CGH X Chromosome (X Chromosome Ultra-High Density Microarray, 954 Genes) |
| 0050198 | CH100 (Complement Activity Enzyme Immunoassay, Total) |
| 0050198 | CH50 (Complement Activity Enzyme Immunoassay, Total) |
| 0051076 | Chagas Antibody, IgG (Trypanosoma cruzi Antibody, IgG)
|
| 0051075 | Chagas Antibody, IgM (Trypanosoma cruzi Antibody, IgM)
|
| 2006222 | CHARGE Syndrome (CHD7) Sequencing
|
| 0093370 | Chemokine co-receptor (Trofile Co-Receptor Tropism Assay) |
| 0092610 | Chenodeoxycholic Acid (Bile Acids, Fractionated & Total by LC-MS/MS) |
| 2002298 | CHIC2/FL1P1 (Chromosome FISH, Interphase) |
| 0099314 | Chicken Pox (Varicella-Zoster Virus Antibody, IgM) |
| 0054445 | Chicken Pox [Varicella-Zoster Virus Antibody, IgM by ELISA (CSF)] |
| 0060283 | Chicken Pox (Varicella-Zoster Virus & Herpes Simplex Virus DFA with Reflex to Varicella-Zoster Virus |
| 0060042 | Chicken Pox (Varicella-Zoster Virus by PCR) |
| 0060282 | Chicken Pox (Varicella-Zoster Virus DFA with Reflex to Varicella-Zoster Virus Culture) |
| 0050167 | Chickenpox (Varicella-Zoster Virus Antibody, IgG) |
| 2007545 | Childhood-Onset Epilepsy Panel, Sequencing and Deletion/Duplication, 40 Genes
|
| 2008100 | Chimerism, Additional Donor
|
| 2002067 | Chimerism, Donor
|
| 2002066 | Chimerism, Post-Transplant
|
| 2002064 | Chimerism, Post-Transplant, Sorted Cells
|
| 2002065 | Chimerism, Recipient Pre-Transplant
|
| 0065100 | Chlamydia Antibody Panel, IgG & IgM by IFA
|
| 0065139 | Chlamydia Antibody Panel, IgG by IFA
|
| 0065105 | Chlamydia Antibody Panel, IgM by IFA
|
| 0060241 | Chlamydia/GC (Chlamydia trachomatis & Neisseria gonorrhoeae by Amplified Detection (APTIMA®))
|
| 0060715 | Chlamydia pneumoniae by PCR
|
| 0060241 | Chlamydia trachomatis and Neisseria gonorrhoeae by Amplified Detection
|
| 0060774 | Chlamydia trachomatis and Neisseria gonorrhoeae by Amplified Detection (APTIMA®), M4/UTM Specimens
|
| 2001551 | Chlamydia trachomatis and Neisseria gonorrhoeae by Amplified Detection (APTIMA®) on SurePath™
|
| 0060734 | Chlamydia trachomatis and Neisseria gonorrhoeae by Amplified Detection (APTIMA®) on ThinPrep™
|
| 0060243 | Chlamydia trachomatis by Amplified Detection
|
| 0060243 | Chlamydia trachomatis by Nucleic Acid Amplification (Chlamydia trachomatis by Amplified Detection (APTIMA(R)))
|
| 0060850 | Chlamydia trachomatis Culture
|
| 0060287 | Chlamydia trachomatis DFA
|
| 0060287 | Chlamydia trachomatis, Fluorescence Staining of MicroTrak Slides (Chlamydia trachomatis DFA)
|
| 0060715 | Chlamydophila pneumoniae (Chlamydia pneumoniae by PCR)
|
| 2002272 | Chlonorchis sinensis (Ova & Parasite Exam, Fecal (Immunocompromised or Travel History))
|
| 0090346 | Chloracol (Chloramphenicol) |
| 0091267 | Chloral Hydrate, Serum or Plasma
|
| 0090346 | Chloramphenicol
|
| 0092520 | Chlorazepate (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Meconium) |
| 0093300 | Chlorazepate (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Serum or Plasma) |
| 0090358 | Chlorazepate (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Urine) |
| 0090148 | Chlordiazepoxide and Metabolite (Librium and Nordiazepam) |
| 0092520 | Chlordiazepoxide (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Meconium) |
| 0093300 | Chlordiazepoxide (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Serum or Plasma) |
| 0090358 | Chlordiazepoxide (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Urine) |
| 0090148 | Chlordiazepoxide (Librium and Nordiazepam) |
| 0020381 | Chloride, Fecal
|
| 0020163 | Chloride, Fluid
|
| 0020003 | Chloride, Serum or Plasma
|
| 0020850 | Chloride, Urine
|
| 0049055 | Chloroacetate Stain (Esterase Stain, Specific) |
| 0090346 | Chloromycetin (Chloramphenicol) |
| 0091310 | Chloroquine, Plasma
|
| 0090870 | Chlorpromazine
|
| 0091216 | Chlorpropamide, Serum or Plasma
|
| 2004279 | Chlorpropamide (Sulfonylurea Hypoglycemics Panel (Qualitative), Serum or Plasma) |
| 0091494 | Chlorpropamide, Urine
|
| 2002461 | Cholangiocarcinoma (Pancreatobiliary FISH) |
| 0020714 | Cholesterol, Fluid
|
| 0020053 | Cholesterol (HDL Cholesterol) |
| 2002043 | Cholesterol (NMR LipoProfile® Test)
|
| 0020031 | Cholesterol, Serum or Plasma
|
| 0092610 | Cholic Acid (Bile Acids, Fractionated & Total by LC-MS/MS) |
| 0020175 | Cholinesterase, RBC & Pseudocholinesterase (Insecticide Exposure Panel) |
| 0020174 | Cholinesterase, RBC/Hb Ratio
|
| 0020167 | Cholinesterase, Serum or Plasma (Pseudocholinesterase, Total) |
| 0020159 | Cholinesterase, Serum (Pseudocholinesterase, Dibucaine Inhibition) |
| 2002291 | chorionic villi |
| 0040203 | Chorionic Villus, FISH
|
| 2001578 | Christmas Disease (Hemophilia B (F9) Sequencing)
|
| 0030100 | Christmas Factor (Factor IX, Activity) |
| 2005287 | Chromatin Antibody, IgG
|
| 2005548 | Chromium, Joint Fluid
|
| 2005528 | Chromium (Metals, Joint Fluid) |
| 0098830 | Chromium, Serum
|
| 0025068 | Chromium, Urine
|
| 0080469 | Chromogranin A
|
| 2003830 | Chromogranin A by Immunohistochemistry
|
| 2005749 | Chromosome Analysis - Breakage, Ataxia Telangiectasia, Whole Blood
|
| 0097688 | Chromosome Analysis - Breakage, Fanconi Anemia
|
| 2002647 | Chromosome Analysis (Acute Lymphocytic Leukemia (ALL) Panel by FISH, Adult) |
| 2002719 | Chromosome Analysis (Acute Lymphocytic Leukemia (ALL) Panel by FISH, Pediatric) |
| 2002653 | Chromosome Analysis (Acute Myelogenous Leukemia (AML) with Myelodysplastic Syndrome (MDS), or Therapy-Related AML, by FISH)
|
| 2002384 | Chromosome Analysis (Acute Myelogenous Leukemia Panel by FISH) |
| 2002293 | Chromosome Analysis, Amniotic Fluid
|
| 2002292 | Chromosome Analysis, Bone Marrow
|
| 2007130 | Chromosome Analysis, Bone Marrow with Reflex to Genomic Microarray
|
| 2002291 | Chromosome Analysis, Chorionic Villus
|
| 2002295 | Chromosome Analysis (Chromosome FISH, CLL Panel) |
| 2002297 | Chromosome Analysis (Chromosome FISH, Prenatal) |
| 2002290 | Chromosome Analysis, Leukemic Blood
|
| 2007131 | Chromosome Analysis, Leukemic Blood with Reflex to Genomic Microarray
|
| 2002300 | Chromosome Analysis, Lymph Node
|
| 2002650 | Chromosome Analysis (Lymphoma (Aggressive) Panel by FISH) |
| 2002294 | Chromosome Analysis (Multiple Myeloma Panel by FISH) |
| 2002360 | Chromosome Analysis (Myeloproliferative Disorders Panel by FISH) |
| 2002289 | Chromosome Analysis, Peripheral Blood
|
| 2005763 | Chromosome Analysis, Peripheral Blood, with Reflex to Genomic Microarray
|
| 2002288 | Chromosome Analysis, Products of Conception
|
| 2005762 | Chromosome Analysis, Products of Conception, with Reflex to Genomic Microarray
|
| 2002287 | Chromosome Analysis, Rule Out Mosaicism
|
| 2002286 | Chromosome Analysis, Skin Biopsy
|
| 2002296 | Chromosome Analysis, Solid Tumor
|
| 2002295 | Chromosome FISH, CLL Panel
|
| 2002298 | Chromosome FISH, Interphase
|
| 2002299 | Chromosome FISH, Metaphase
|
| 2006270 | Chromosome FISH, Multiple Myeloma Panel Process and Hold
|
| 2002297 | Chromosome FISH, Prenatal
|
| 0092572 | Chronic Bullous Disease (Cutaneous Direct Immunofluorescence, Biopsy) |
| 2006356 | Chronic Granulomatous Disease (CYBB Gene Scanning and NCF1 Exon 2 GT Deletion) with Reflex to CYBB Sequencing
|
| 2006366 | Chronic Granulomatous Disease (NCF1) Exon 2 GT Deletion
|
| 2006361 | Chronic Granulomatous Disease, X-Linked (CYBB) Gene Scanning with Reflex to Sequencing
|
| 0020089 | Chronic Hepatitis Profile (Type B) (Hepatitis B Virus Surface Antigen with Reflex to Confirmation) |
| 0020095 | Chronic Hepatitis Profile (Type B) (Hepatitis Be Virus Antibody) |
| 0020094 | Chronic Hepatitis Profile (Type B) (Hepatitis Be Virus Antigen) |
| 0020089 | Chronic Hept Scrn B (Hepatitis B Virus Surface Antigen with Reflex to Confirmation) |
| 2002295 | Chronic Lymphocytic Leukemia (Chromosome FISH, CLL Panel) |
| 0093194 | Chronic Lymphocytic Leukemia Follow up Phenotyping by Flow Cytometry
|
| 2005415 | Chronic Urticaria Panel (Urticaria-Inducing Activity w/ Thyroid Antibodies and Stimulating Hormone) |
| 2005416 | Chronic Urticaria (Urticaria-Induced Basophil Activation) |
| 2005413 | Chronic Urticaria (Urticaria-Inducing Activity) |
| 2005415 | Chronic Urticaria (Urticaria-Inducing Activity with Thyroid Antibodies and Stimulating Hormone) |
| 2002970 | Chuvash Polycythemia (von Hippel-Lindau (VHL) Sequencing)
|
| 0098457 | Chylomicron Screen, Body Fluid
|
| 2005160 | Chymotrypsin, Fecal
|
| 0050138 | CICA (Cytoplasmic Islet Cell Antibody) (Islet Cell Antibody, IgG) |
| 0091337 | Cimetidine, Serum or Plasma
|
| 2004067 | CIP1 (p21 (Waf1/Cip 1) by Immunohistochemistry |
| 2003302 | Cipramil® (Citalopram, Serum or Plasma)
|
| 0050301 | Circulating Immune Complex Detection (C1Q Binding Assay) |
| 0050667 | Circulating Immune Complex Panel (Immune Complex Panel) |
| 0093399 | Circulating Tumor Cell Count
|
| 0093399 | Circulating Tumor Cells, Breast, Colon, Prostate (Circulating Tumor Cell Count (Cell Search))
|
| 2003302 | Citalopram, Serum or Plasma
|
| 0080011 | Citrate (Citric Acid, Serum) |
| 0020852 | Citrate (Citric Acid, Urine) |
| 0020852 | Citric Acid (Citrate), Random Urine (Citric Acid, Urine) |
| 0020852 | Citric Acid (Citrate)/Creatinine Ratio, Random Urine (Citric Acid, Urine) |
| 0080011 | Citric Acid, Serum
|
| 0020852 | Citric Acid, Urine
|
| 2001961 | Citrin Deficiency (SLC25A13) Sequencing (Familial Mutation, Targeted Sequencing) |
| 2006261 | Citrin Deficiency (SLC25A13) Sequencing
|
| 0055256 | Citrullinated Antibody (Cyclic Citrullinated Peptide (CCP) Antibody, IgG) |
| 0055256 | Citrullinated Protein/Peptide Antibody (ACPA) (Cyclic Citrullinated Peptide (CCP) Antibody, IgG) |
| 0055256 | Citrulline Antibody (Cyclic Citrullinated Peptide (CCP) Antibody, IgG) |
| 2007069 | Citrullinemia, Type I (ASS1) Sequencing
|
| 2001961 | Citrullinemia, Type I (ASS1) (Familial Mutation, Targeted Sequencing) |
| 2008095 | CJD |
| 2003851 | CK 5,6 (Cytokeratin 5,6 (CK 5,6) by Immunohistochemistry) |
| 2003854 | CK 7 (Cytokeratin 7 (CK 7) by Immunohistochemistry) |
| 2003845 | CK 19 (Cytokeratin 19 (CK 19) by Immunohistochemistry) |
| 2003848 | CK 20 (Cytokeratin 20 (CK 20) by Immunohistochemistry) |
| 0020010 | CK (Creatine Kinase, Total, Serum or Plasma) |
| 0020414 | CK Isoenzymes (Creatine Kinase Isoenzymes) |
| 0020414 | CKBB (Creatine Kinase Isoenzymes) |
| 2002674 | cKIT (Gastrointestinal Stromal Tumor Mutation) |
| 0040137 | CKIT (KIT (D816V) Mutation by PCR, Fluid)
|
| 2002695 | cKIT (KIT Mutations, Melanoma)
|
| 0020414 | CKMB (Creatine Kinase Isoenzymes) |
| 0050198 | Classic Complement Pathway Assessment-CH100 (Complement Activity Enzyme Immunoassay, Total) |
| 0099336 | Clomipramine and Metabolite, Serum or Plasma
|
| 0096048 | Clomipramine Metabolite (Antidepressant Panel Quantitation, Urine) |
| 0091319 | Clon (Ethambutol, Serum or Plasma) |
| 0090055 | Clonazepam
|
| 0092520 | Clonazepam (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Meconium) |
| 0093300 | Clonazepam (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Serum or Plasma) |
| 0090358 | Clonazepam (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Urine) |
| 0091362 | Clonidine, Serum or Plasma
|
| 0091223 | Clonidine, Urine
|
| 0092520 | Clonopin (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Meconium) |
| 0093300 | Clonopin (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Serum or Plasma) |
| 0090358 | Clonopin (Drugs of Abuse Confirmation/Quantitation - Benzodiazepines - Urine) |
| 0051104 | Clopidogrel ( Cytochrome P450 2C19 (CYP2C19) 9 Mutations)
|
| 0090196 | Clorazepate (Tranxene {R}) (Clorazepate (Assayed as Nordiazepam)) |
| 0090196 | Clorazepate (Assayed as Nordiazepam)
|
| | Clostridium botulinum Culture
|
| 0060140 | Clostridium difficile Culture with Reflex to Cytotoxin Cell Assay
|
| 2002552 | Clostridium difficile Cytotoxin Antibody by Neutralization
|
| 0060851 | Clostridium difficile Cytotoxin Cell Assay
|
| 2002838 | Clostridium difficile toxin B gene (tcdB) by PCR
|
| 0065146 | Clostridium difficile Toxins (A & B) by EIA
|
| 2002819 | Clot Solubility
|
| 0098930 | Clozapine
|
| 2006476 | Clozapine and Metabolite, Serum or Plasma
|
| 0098930 | Clozaril (Clozapine) |
| 2006476 | Clozaril®
|
| 0050165 | CMV Ab, Quantitative (Cytomegalovirus Antibody, IgG) |
| 0050622 | CMV Antibodies (Cytomegalovirus Antibodies, IgG & IgM) |
| 0050165 | CMV Antibody (Cytomegalovirus Antibody, IgG) |
| 0050553 | CMV Antibody (Cytomegalovirus Antibody, IgM) |
| 0065004 | CMV Culture (Cytomegalovirus Rapid Culture) |
| 0050553 | CMV (Cytomegalovirus Antibody, IgM) |
| 2004760 | CMV (Cytomegalovirus Antiviral Drug Resistance by Sequencing) |
| 0060040 | CMV (Cytomegalovirus by PCR) |
| 2003833 | CMV (Cytomegalovirus (CMV) by Immunohistochemistry) |
| 2004760 | CMV Genotype (Cytomegalovirus Antiviral Drug Resistance by Sequencing) |
| 2004760 | CMV Resistance (Cytomegalovirus Antiviral Drug Resistance by Sequencing) |
| 0099231 | Co (Cobalt, Blood) |
| 0025032 | Co (Cobalt, Urine) |
| 2005757 | Co-ox |
| 2005757 | Co-oximetry |
| 0030007 | Coagulation Factor II Activity Assay, Plasma (Factor II, Activity (Prothrombin)) |
| 0030075 | Coagulation Factor V Activity Assay, Plasma (Factor V, Activity) |
| 0030075 | Coagulation Factor VII Activity Assay, Plasma (Factor V, Activity) |
| 0030095 | Coagulation Factor VIII Activity Assay, Plasma (Factor VIII, Activity) |
| 0030026 | Coagulation Factor VIII Inhibitor Panel, Plasma (Factor VIII Activity with Reflex to Bethesda Quantitative, Factor VIII)
|
| 0030100 | Coagulation Factor IX Activity Assay, Plasma (Factor IX, Activity) |
| 0030032 | Coagulation Factor IX Inhibitor, Plasma (Factor IX Activity with Reflex to Bethesda Quantitative, Factor IX)
|
| 0030110 | Coagulation Factor XI Activity Assay, Plasma (Factor XI, Activity) |
| 0030115 | Coagulation Factor XII Activity Assay, Plasma (Factor XII, Activity) |
| 0030105 | Coagulation Factor X Activity Assay, Plasma (Factor X, Activity) |
| 0099231 | COB (Cobalt, Blood) |
| 0099431 | Cobalamin Deficiency (Methylmalonic Acid, Serum or Plasma (Vitamin B12 Deficiency)
|
| 0070150 | Cobalamin (Vitamin B12)
|
| 0099231 | Cobalt, Blood
|
| 2005549 | Cobalt, Joint Fluid
|
| 2005528 | Cobalt (Metals, Joint Fluid) |
| 0025037 | Cobalt, Serum or Plasma
|
| 0025032 | Cobalt, 24-Hour Urine (Cobalt, Urine) |
| 0025032 | Cobalt, Urine
|
| 0025032 | Cobalt/Creatinine, Random, Urine (Cobalt, Urine) |
| 0092312 | Cocaethylene (Drugs of Abuse Confirmation/Quantitation - Cocaine & Metabolites - Meconium) |
| 0090684 | Cocaethylene (Drugs of Abuse Confirmation/Quantitation - Cocaine & Metabolites - Serum or Plasma) |
| 0092312 | Cocaine and Metabolites - Confirmation/Quantitation - Meconium
|
| 0092312 | Cocaine (Drugs of Abuse Confirmation/Quantitation - Cocaine & Metabolites - Meconium) |
| 0090684 | Cocaine (Drugs of Abuse Confirmation/Quantitation - Cocaine & Metabolites - Serum or Plasma) |
| 0090359 | Cocaine (Drugs of Abuse Confirmation/Quantitation - Cocaine Metabolite (Benzoylecgonine) - Urine) |
| 0060045 | Coccidia (Cryptosporidium Antigen by EIA)
|
| 0060046 | Coccidia (Parasitology Stain by Modified Acid-Fast) |
| 0055591 | Coccidia (Toxoplasma gondii by PCR)
|
| 0050137 | Coccidioides Antibodies, IgG & IgM by ELISA
|
| 0050710 | Coccidioides Antibodies Panel, CSF by CF, ID, ELISA
|
| 0050588 | Coccidioides Antibodies Panel, Serum by CF, ID, ELISA
|
| 0050183 | Coccidioides Antibody (TP Antigen) (Coccidioides Ab by ID) |
| 0050183 | Coccidioides Antibody (TP Antigen), Immunodiffusion (Coccidioides Ab by ID) |
| 0050170 | Coccidioides Antibody by CF
|
| 0050183 | Coccidioides Antibody by ID
|
| 0050179 | Coccidioides Antibody, IgG by ELISA
|
| 0050178 | Coccidioides Antibody, IgM by ELISA
|
| 0062225 | Coccidioides immitis Identification by DNA Probe
|
| 0050170 | Coccidioidomycosis IgG/IgM (Coccidioides Antibody by CF)
|
| 0050183 | Coccidioidomycosis IgG/IgM (Coccidioides Antibody by ID)
|
| 0092354 | Codeine and Metabolite (Drugs of Abuse Confirmation/Quantitation - Opiates - Serum or Plasma) |
| 0092314 | Codeine (Drugs of Abuse Confirmation/Quantitation - Opiates - Meconium) |
| 0092354 | Codeine (Drugs of Abuse Confirmation/Quantitation - Opiates - Serum or Plasma) |
| 0090364 | Codeine (Drugs of Abuse Confirmation/Quantitation - Opiates - Urine) |
| 0051358 | Coeliac Disease Antibodies (Deamidated Gliadin Peptide (DGP) Antibodies, IgA & IgG) |
| 0051357 | Coeliac Disease Antibodies (Deamidated Gliadin Peptide (DGP) Antibody, IgA) |
| 0081119 | Coenzyme Q10, Total
|
| 0091516 | Cogentin® (Benztropine, Serum or Plasma)
|
| 0091098 | Cogentin® (Benztropine, Urine)
|
| 0050175 | Cold Agglutinins
|
| 2003839 | Collagen IV by Immunohistochemistry
|
| 0070416 | Collagen C Telopeptide (C-Telopeptide, Beta-Cross-Linked, Serum) |
| 0070416 | Collagen Type I-C Telopeptide (C-Telopeptide, Beta-Cross-Linked, Serum) |
| 0093167 | Colorado Tick Fever Antibodies, IgG & IgM, IFA
|
| 2003243 | ColoVantage (Septin 9 (SEPT9), Methylated DNA Detection by Real-Time PCR)
|
| 0092314 | Combunox (Drugs of Abuse Confirmation/Quantitation - Opiates - Meconium) |
| 0090364 | Combunox (Drugs of Abuse Confirmation/Quantitation - Opiates - Urine) |
| 0030007 | Common Pathway Proteins, Factor II (Factor II, Activity (Prothrombin)) |
| 0030075 | Common Pathway Proteins, Factor V (Factor V, Activity) |
| 0030105 | Common Pathway Proteins, Factor X (Factor X, Activity) |
| 2002366 | Comparative Genomic Hybridization (Microarray Genomic, Fetal) |
| 0091418 | Compazine® (Phenothiazines, Serum or Plasma - Screen with Reflex to Confirmation/Quantitation)
|
| 0091417 | Compazine® (Phenothiazines, Urine - Screen with Reflex to Confirmation/Quantitation)
|
| 0091426 | Compazine® (Prochlorperazine (Compazine®), Serum or Plasma)
|
| 0091427 | Compazine® (Prochlorperazine (Compazine®), Urine)
|
| 2005373 | Complement Activity, Alternative Pathway (AH50)
|
| 0050198 | Complement Activity Enzyme Immunoassay, Total
|
| 0050198 | Complement CH100, Total (Complement Activity Enzyme Immunoassay, Total) |
| 0099078 | Complement Component 1, Functional
|
| 0099130 | Complement Component 1Q Level
|
| 0050148 | Complement Component 2
|
| 0050150 | Complement Component 3
|
| 2003304 | Complement Component 3A
|
| 0050155 | Complement Component 4
|
| 2003180 | Complement Component 4A
|
| 0050156 | Complement Component 5
|
| 0099072 | Complement Component 6
|
| 0099131 | Complement Component 6 Functional
|
| 0099073 | Complement Component 7
|
| 0099121 | Complement Component 7 Functional
|
| 0099074 | Complement Component 8
|
| 0099133 | Complement Component 8 Functional
|
| 0099076 | Complement Component 9
|
| 0099120 | Complement Component 9 Functional
|
| 2008097 | Complement Component 1q, Functional
|
| 2003499 | Complement Component C9 (CCC9) by Immunohistochemistry
|
| 0099130 | Complement Component C1q (Complement Component 1q Level) |
| 0050149 | Complement Components 3 and 4
|
| 0051720 | Complement Factor B
|
| 2007479 | Comprehensive hybrid, TOF, high res, high-res
|
| 0020408 | Comprehensive Metabolic Panel
|
| 2003114 | Concerta (Methylphenidate & Metabolite - Confirmation/Quantitation - Serum or Plasma) |
| 2003115 | Concerta (Methylphenidate and Metabolite - Confirmation/Quantitation - Urine) |
| 0065999 | Condyloma (Human Papillomavirus (HPV) DNA Probe, High Risk, Cervical Brush (Digene)) |
| 0060744 | Condyloma (Human Papillomavirus (HPV) DNA Probe, High Risk Surepath® (AutoCyte))
|
| 0060750 | Condyloma (Human Papillomavirus (HPV) DNA Probe, High Risk (ThinPrep®))
|
| 0092330 | Congenital Adrenal Hyperplasia (Adrenal Steroid Quantitative Panel by LC-MS/MS, Serum or Plasma) |
| 2002282 | Congenital Adrenal Hyperplasia Panel, 11-Beta Hydroxylase Deficiency
|
| 2002283 | Congenital Adrenal Hyperplasia Panel, 21-Hydroxylase Deficiency
|
| 2002029 | Congenital Adrenal Hyperplasia Treatment Panel
|
| 2006220 | Congenital Amegakaryocytic Thrombocytopenia (CAMT) Sequencing
|
| 2002918 | Congenital Disorders of Glycosylation (Carbohydrate Deficient Transferrin for Congenital Disorders of Glycosylation)
|
| 0049010 | Congenital Dyserythropoietic Anemia Type II (Acid Hemolysin (Ham Test)) |
| 2006593 | Congenital Erythropoietic Porphyria (CEP) |
| 2002970 | Congenital Polycythemia (von Hippel-Lindau (VHL) Sequencing)
|
| 2002965 | Congenital Polycythemia (von Hippel-Lindau (VHL) Sequencing and Deletion/Duplication)
|
| 0095899 | Congential T and B Cell Immunodeficiencies (Lymphocyte Subset Panel 7 - Congenital Immunodeficiencies)
|
| 8209713 | Conjunctival Scrapings for Cytology (Cytology, Conjunctival Scraping) |
| 0050080 | Connective Tissue Disease (Anti-Nuclear Antibodies (ANA), IgG by ELISA with Reflex to ANA, IgG by IF
|
| 0050317 | Connective Tissue Disease (Anti-Nuclear Antibodies (ANA), IgG by ELISA with Reflexes to ANA, IgG by IFA and to dsDNA, RNP, Smith, SSA, and SSB Antibodies, IgG)
|
| 0050653 | Connective Tissue Disease (Extractable Nuclear Antigen Antibodies (RNP, Smith, Scleroderma, SSA, & SSB))
|
| 0051668 | Connective Tissue Diseases Profile
|
| 2001961 | Connexin 26 (GJB2) (Familial Mutation, Targeted Sequencing)
|
| 0051374 | Connexin 26 (GJB2), Sequencing
|
| | Consultation, Cytopathology
|
| | Consultation, Dermatopathology
|
| | Consultation, Head and Neck
|
| | Consultation, Hematopathology
|
| | Consultation, Neuropathology
|
| | Consultation, Surgical Pathology
|
| 0013008 | Coombs, Direct (Direct Coombs (Anti-Human Globulin)) |
| 0025055 | Copper (Cu) (Heavy Metals Panel 6, Urine with Reflex to Arsenic Fractionated) |
| 0020598 | Copper, Free (Wilson Disease Screening Panel, Serum) |
| 0020596 | Copper Index (Copper, Serum Free (Direct)) |
| 0020694 | Copper, Liver
|
| 0020598 | Copper Panel (Wilson Disease Screening Panel, Serum) |
| 2007252 | Copper, RBC
|
| 0020096 | Copper, Serum
|
| 0020596 | Copper, Serum Free (Direct)
|
| 0020461 | Copper, Urine
|
| 0020461 | Copper/Creatinine Ration, Urine (Copper, Urine) |
| 0099824 | Coproporphyrinl (Porphyrins, Fecal) |
| 2006593 | Coproporphyrin, EPP |
| 0090161 | Cordarone (Amiodarone and Metabolite) |
| 2003292 | CordStat 12 Reflexive Panel
|
| 0060142 | Corneal Culture (Eye Culture) |
| 0020421 | Coronary Risk Panel (Lipid Panel) |
| 0020468 | Coronary Risk Panel (Lipid Panel, Extended) |
| 0098513 | Corticosteroid Binding Globulin (CBG)
|
| 0098513 | Corticosteroid-binding Globulin (CBG) Transcortin (Corticosteroid Binding Globulin (CBG)) |
| 0070031 | Cortisol (Adrenocorticotropic Hormone Stimulation, 0 Minutes) |
| 0070032 | Cortisol (Adrenocorticotropic Hormone Stimulation, 30 Minutes) |
| 0070033 | Cortisol (Adrenocorticotropic Hormone Stimulation, 60 Minutes) |
| 2003250 | Cortisol by LC-MS/MS, Serum or Plasma
|
| 0092100 | Cortisol/Cortisone Urine Free by LC-MS/MS
|
| 0098391 | Cortisol, Free
|
| 0081117 | Cortisol, Saliva
|
| 0070030 | Cortisol, Serum or Plasma
|
| 0097222 | Cortisol Urine Free by LC-MS/MS
|
| 0097222 | Cortisol, Free, LC/MS/MS, Second Void Urine (Cortisol Urine Free by LC-MS/MS) |
| 2003252 | Cortisone by LC-MS/MS, Serum or Plasma
|
| 0092331 | Cortodoxone (11-Deoxycortisol Quantitative by LC-MS/MS, Serum or Plasma) |
| 0060360 | Corynebacterium diphtheriae Culture
|
| 0025037 | COS (Cobalt, Serum or Plasma) |
| 0092361 | Cotinine (Nicotine & Metabolites, Serum or Plasma) |
| 0092356 | Cotinine (Nicotine & Metabolites, Urine) |
| 2007081 | Cotinine Screen, Urine
|
| 0020044 | CoTrimazine, Ingredient of (Sulfonamides (Sulfas)) |
| 0025032 | COU (Cobalt, Urine) |
| 0090805 | Coumadin (Warfarin, Serum or Plasma) |
| 0091230 | Coumadin, Urine (Warfarin, Urine) |
| 2001961 | Cowden Syndrome (PTEN) Sequencing (Familial Mutation, Targeted Sequencing)
|
| 2002726 | Cowden Syndrome (PTEN-Related Disorders (PTEN) Deletion/Duplication)
|
| 2002722 | Cowden Syndrome (PTEN-Related Disorders (PTEN) Sequencing)
|
| 2003102 | Coxiella burnetii (Q-Fever) Antibodies, IgG & IgM by IFA with Reflex to Titer
|
| 0050462 | Coxiella burnetii (Q-Fever) Antibody IgG, Phase I & II by IFA
|
| 0050463 | Coxiella burnetii (Q-Fever) Antibody IgG, Phase I by IFA
|
| 0050464 | Coxiella burnetii (Q-Fever) Antibody IgG, Phase II by IFA
|
| 2002932 | Coxsackie A Antibodies (A-2, 4, 7, 9, 10 & 16 Serotypes)
|
| 0050503 | Coxsackie A9 Virus Antibodies by CF
|
| 0060055 | Coxsackie B Virus Antibodies
|
| 0050249 | Coxsackie Virus (Enterovirus Detection by RT-PCR) |
| 0020414 | CPK Isoenzymes (Creatine Phosphokinase Isoenzymes) |
| 0098830 | Cr, Blood (Chromium, Serum) |
| 0025068 | Cr (Chromium, Urine) |
| 0092312 | Crack (Drugs of Abuse Confirmation/Quantitation - Cocaine & Metabolites - Meconium) |
| 0090684 | Crack (Drugs of Abuse Confirmation/Quantitation - Cocaine & Metabolites - Serum or Plasma) |
| 0090359 | Crack (Drugs of Abuse Confirmation/Quantitation - Cocaine Metabolite (Benzoylecgonine) - Urine) |
| 2002328 | Creatine Disorders Panel, Plasma or Serum
|
| 2002333 | Creatine Disorders Panel, Urine
|
| 0020414 | Creatine Kinase Isoenzymes
|
| 0080480 | Creatine Kinase, MB
|
| 0020010 | Creatine Kinase, Total, Serum or Plasma
|
| 2002340 | Creatine, Serum or Plasma
|
| 2001875 | Creatine Transport, Fibroblasts
|
| 2002343 | Creatine, Urine
|
| 0020473 | Creatinine, 24-Hour Urine
|
| 0020509 | Creatinine, Body Fluid
|
| 0020474 | Creatinine Clearance, Urine
|
| 0020473 | Creatinine, Random Urine (Creatinine, 24-Hour Urine) |
| 0020025 | Creatinine, Serum or Plasma
|
| 0091485 | Cresols, Urine
|
| 2008095 | Creutzfeldt-Jakob Disease |
| 2002299 | Cri-Du-Chat (Chromosome FISH, Metaphase) |
| 0050215 | Crithidia luciliae (Double-Stranded DNA (dsDNA) Antibody, IgG by ELISA with Reflex to dsDNA Antibody, IgG by IFA)
|
| 2001613 | Crohn Disease Prognostic Panel
|
| 0070500 | Cross-Linked N-Telopeptide (N-Telopeptide, Cross-Linked, Serum) |
| 0070062 | Cross-Linked N-Telopeptide (N-Telopeptide, Cross-Linked, Urine) |
| 0050180 | CRP (C-Reactive Protein) |
| 0050182 | CRP High Sensitivity (C-Reactive Protein, High Sensitivity) |
| 0098830 | CRS (Chromium, Serum) |
| 0025068 | CRU (Chromium, Urine) |
| 0050190 | Cryofibrinogen
|
| 0050190 | Cryofibrinogen, Qualitative, Plasma (Cryofibrinogen) |
| 0050185 | Cryoglobulin, Qualitative
|
| 2002403 | Cryoglobulin, Qualitative with Reflex to IFE Typing and Quantitative IgA, IgG, and IgM
|
| 2002063 | Cryoglobulin, Qualitative, with Reflex to Quantitative IgA, IgG, and IgM
|
| 0098947 | Cryptococcus Antibody
|
| 0050195 | Cryptococcus Antigen, CSF
|
| 0050196 | Cryptococcus Antigen, Serum
|
| 0050196 | Cryptococcus Antigen, Serum (Cryptococcus Antigen, Serum) |
| 0050195 | Cryptococcus Antigen, Spinal Fluid (Cryptococcus Antigen, CSF) |
| 2004593 | Cryptococcus Exam (India Ink Stain)
|
| 0060045 | Cryptosporidium Antigen by EIA
|
| 0060045 | Cryptosporidium Antigen (Cryptosporidium Antigen by EIA)
|
| 0060046 | Cryptosporidium/Cyclospora Stain (Parasitology Stain by Modified Acid-Fast)
|
| 0009500 | Crystals (Local Clients Only)
|
| 0090085 | Crystodigin® (Digitoxin)
|
| 0020163 | CSF Chloride (Chloride, Fluid) |
| 0050047 | CSF Leakage Detection (Beta-2 Transferrin) |
| 0050047 | CSF-Specific Transferrin (Beta-2 Transferrin) |
| 0060241 | CT/NG (Chlamydia trachomatis & Neisseria gonorrhoeae by Amplified Detection (APTIMA®))
|
| 0093399 | CTC (Circulating Tumor Cell Count (Cell Search))
|
| 2007069 | CTLN1 (ASS1) Sequencing
|
| 0070416 | CTx (C-Telopeptide, Beta-Cross-Linked, Serum) |
| 0020694 | Cu (Copper, Liver) |
| 0020096 | Cu (Copper, Serum) |
| 0020596 | Cu (Copper, Serum Free (Direct)) |
| 0020461 | Cu (Copper, Urine) |
| 0020096 | Cu, Plasma (Copper, Serum) |
| 0020596 | Cu, Plasma (Copper, Serum Free (Direct)) |
| 0020596 | CuFree (Copper, Serum Free (Direct)) |
| 0060152 | Culture (AFB Culture (Includes AFB Stain 0060151)) |
| 0060143 | Culture, Anaerobic |
| 0060102 | Culture, Blood (Blood Culture) |
| 0060024 | Culture, Blood for AFB & Fungus (Blood Culture, AFB & Fungal) |
| 0060070 | Culture, Blood for Fungus (Blood Culture, Fungal) |
| 0060108 | Culture, Body Fluid |
| 0060103 | Culture, Bone (Bone Culture) |
| 0060104 | Culture, Bone Marrow (Bone Marrow Culture) |
| 0060117 | Culture, Bordetella pertussis (Bordetella pertussis Culture)
|
| 0060159 | Culture, Brucella (Brucella Culture)
|
| 0060135 | Culture, Campylobacter (Stool Culture, Campylobacter)
|
| 0060140 | Culture, Clostridium difficile (Clostridium difficile Culture with Reflex to Cytotoxin Cell Assay)
|
| 0065004 | Culture, CMV (Cytomegalovirus Rapid Culture) |
| 0060360 | Culture, Corynebacterium diphtheriae (Corynebacterium diphtheriae Culture)
|
| 0060130 | Culture, Cystic Respiratory (Cystic Respiratory Culture) |
| 0060361 | Culture, Ear (Ear Culture) |
| 0060142 | Culture, Eye (Eye Culture) |
| 0060149 | Culture, Fungus (Fungal Culture) |
| 0065005 | Culture, HSV (Herpes Simplex Virus Culture) |
| 0060113 | Culture, Legionella sp. (Legionella Species, Culture)
|
| 0060158 | Culture, Leptospira (Leptospira Culture)
|
| 0065056 | Culture, Mumps (Mumps Virus Culture) |
| 0065031 | Culture, Mycoplasma hominis and Ureaplasma urealyticum (Ureaplasma urealyticum & Mycoplasma hominis Culture)
|
| 0060093 | Culture, Nocardia (Nocardia Culture (Includes Gram stain 0060101))
|
| 0060163 | Culture Referred for Identification, Fungus (Fungal (Mould/Yeast) Identification) |
| 0060999 | Culture Referred for Identification, Mycobacterium (AFB Identification) |
| 0060122 | Culture, Respiratory (Respiratory Culture (Includes Gram Stain 0060101)) |
| 0065055 | Culture, Rubeola (Measles) |
| 0060124 | Culture, Staphylococcus (Staphylococcus Surveillance Culture)
|
| 0060134 | Culture, Stool (Stool Culture, Routine (Includes E. coli Shiga-like Toxin by EIA 0060047))
|
| 0060126 | Culture (Streptococcus (Group A) Culture)
|
| 0060127 | Culture, Tissue (Tissue Culture (Includes Gram Stain 0060101)) |
| 0060131 | Culture, Urine (Urine Culture) |
| 0060136 | Culture, Vibrio (Stool Culture, Vibrio)
|
| 0060363 | Culture, VRE (Vancomycin-Resistant Enterococcus (VRE) Culture)
|
| 0060132 | Culture, Wound (Wound Culture (Includes Gram Stain 0060101)) |
| 0060137 | Culture, Yersinia (Stool Culture, Yersinia)
|
| 0060060 | Culture, Blood for AFB (Blood Culture, AFB) |
| 0060110 | Culture, Neisseria gonorrhoeae (Gonorrhea Culture)
|
| 2008116 | Culture, Urine Invasive Collection (Urine Culture, Invasive Collection)
|
| 0020096 | CUS (Copper, Serum) |
| 0092572 | Cutaneous Direct Immunofluorescence, Biopsy
|
| 0092572 | Cutaneous Herpetiformis (Cutaneous Direct Immunofluorescence, Biopsy) |
| 0020461 | CUU (Copper, Urine) |
| 2007569 | CVID/CVID2 (TACI-Associated Common Variable Immunodeficiency (TNFRSF13B) Sequencing)
|
| 2002291 | CVS |
| 2002044 | CX26 SEQ (Hearing Loss, Nonsyndromic, Mitochondrial DNA 2 Mutations) |
| 0090060 | Cyanide
|
| 0020457 | Cyclase Activating Parathyroid Hormone (Hepatitis Panel, Acute with Reflex to HBsAg Confirmation) |
| 0095611 | Cyclase Activating Parathyroid Hormone (Parathyroid Hormone, CAP) |
| 0070181 | Cyclic AMP, Nephrogenous
|
| 0070180 | Cyclic AMP, Plasma
|
| 0070485 | Cyclic AMP, Urine
|
| 0055256 | Cyclic Citrullinated Peptide (CCP) Antibody, IgG
|
| 2003842 | Cyclin D1, SP4 by Immunohistochemistry
|
| 0091303 | Cyclobenzaprine (Flexeril), Serum or Plasma
|
| 0091155 | Cyclobenzaprine (Flexeril), Urine
|
| 0060046 | Cyclospora Stain (Parasitology Stain by Modified Acid-Fast)
|
| 0070035 | Cyclosporine A by Tandem Mass Spectrometry
|
| 0058902 | Cyclosporine A, C2 by Tandem Mass Spectrometry
|
| 0070035 | Cyclosporine (Cyclosporine A by Tandem Mass Spectrometry) |
| 0081344 | CYFRA 21-1 (Cytokeratin 19 Fragment (CYFRA 21-1), Serum) |
| 0081344 | CYFRA 21-1 (Cytokeratin 19 Fragment), Serum
|
| 0091558 | Cylert® (Pemoline, Serum or Plasma)
|
| 2006473 | Cymbalta(R) |
| 0051232 | CYP2D6 ( Cytochrome P450 2D6 (CYP2D6) 14 Mutations & Gene Duplication)
|
| 0095229 | Cystatin C, Serum
|
| | Cystic Fibrosis - Test Description and Order Recommendations
|
| 0056003 | Cystic Fibrosis (CFTR) 5T Mutation
|
| 0050098 | Cystic Fibrosis (CFTR) 3199del6 Mutation
|
| 2001933 | Cystic Fibrosis (CFTR) 32 Mutations
|
| 2001969 | Cystic Fibrosis (CFTR) 32 Mutations, Atypical
|
| 2001970 | Cystic Fibrosis (CFTR) 32 Mutations, Fetal
|
| 2001968 | Cystic Fibrosis (CFTR) 32 Mutations with Reflex to Sequencing
|
| 2001967 | Cystic Fibrosis (CFTR) 32 Mutations with Reflex to Sequencing and Reflex to Deletion/Duplication
|
| 0051642 | Cystic Fibrosis (CFTR) Deletion/Duplication
|
| 2001961 | Cystic Fibrosis (CFTR) (Familial Mutation, Targeted Sequencing)
|
| 2001980 | Cystic Fibrosis (CFTR) (Familial Mutation, Targeted Sequencing, Fetal)
|
| 0051110 | Cystic Fibrosis (CFTR) Sequencing
|
| 0051640 | Cystic Fibrosis (CFTR) Sequencing with Reflex to Deletion/Duplication
|
| 0056006 | Cystic Fibrosis Cis-Trans(CFTR) R117H and 5T Mutations
|
| 2002291 | cystic hygroma |
| 2002293 | cystic hygroma |
| 0060130 | Cystic Respiratory Culture
|
| 0055284 | Cysticercosis Antibody, IgG by ELISA
|
| 0055285 | Cysticercosis Antibody, IgG by ELISA (CSF)
|
| 0055283 | Cysticercosis Antibody, IgG by Western Blot
|
| 0055282 | Cysticercosis Antibody, IgG by Western Blot (CSF)
|
| 0080710 | Cystine (Amino Acids Quantitative, Plasma) |
| 0081106 | Cystine Quantitative, Urine
|
| 0081105 | Cystinuria Panel
|
| 2003978 | Cyto HMW (Keratin 903 (K903) High Molecular Weight by Immunohistochemistry) |
| 0051103 | Cytochrome P450 2C9 (CYP2C9) 2 Mutations
|
| 0051104 | Cytochrome P450 2C19 (CYP2C19) 9 Mutations
|
| 0051104 | Cytochrome P450 2C19 Genotype by Sequencing Analysis, Saliva (Cytochrome P450 2C19 (CYP2C19) 9 Mutations)
|
| 0051103 | Cytochrome P450 2C9 Genotype by Sequencing Analysis, Saliva (Cytochrome P450 2C9 (CYP2C9) 2 Mutations)
|
| 0051232 | Cytochrome P450 2D6 (CYP2D6) 14 Mutations and Gene Duplication
|
| 0051232 | Cytochrome P450 2D6 Genotype for Tamoxifen Hormonal Therapy, Saliva (Cytochrome P450 2D6 (CYP2D6) 14 Mutations & Gene Duplication)
|
| 0050543 | Cytogenetics, High Resolution & Fragile X DNA ( Fragile X (FMR1) Diagnostic, Fetal)
|
| 2003414 | Cytogenomic SNP Microarray
|
| 2002366 | Cytogenomic SNP Microarray - Fetal
|
| 2006325 | Cytogenomic SNP Microarray - Oncology
|
| 2006267 | Cytogenomic SNP Microarray Buccal Swab
|
| 2003851 | Cytokeratin 5,6 (CK 5,6) by Immunohistochemistry
|
| 2003854 | Cytokeratin 7 (CK 7) by Immunohistochemistry
|
| 2003493 | Cytokeratin 8,18 Low Molecular Weight (CAM 5.2) by Immunohistochemistry
|
| 2003845 | Cytokeratin 19 (CK 19) by Immunohistochemistry
|
| 2003848 | Cytokeratin 20 (CK 20) by Immunohistochemistry
|
| 2003978 | Cytokeratin High Molecular Weight (Keratin 903 (K903) High Molecular Weight by Immunohistochemistry) |
| 0051394 | Cytokine Panel 12 by MAFD
|
| 0051524 | Cytokine Panel, Monokines by MAFD
|
| 0051408 | Cytokine Panel, TH1 by MAFD
|
| 0051518 | Cytokine Panel, TH2 by MAFD
|
| 0051540 | Cytokine Production by Mononuclear Cells in Response to Mitogen Stimulation, 12 Cytokines
|
| 0051574 | Cytokine Production by Mononuclear Cells in Response to Mitogen Stimulation, Interferon gamma
|
| 0051580 | Cytokine Production by Mononuclear Cells in Response to Mitogen Stimulation, Interleukin 1 beta
|
| 0051571 | Cytokine Production by Mononuclear Cells in Response to Mitogen Stimulation, Interleukin 2
|
| 0051572 | Cytokine Production by Mononuclear Cells in Response to Mitogen Stimulation, Interleukin 2 Receptor (Soluble)
|
| 0051576 | Cytokine Production by Mononuclear Cells in Response to Mitogen Stimulation, Interleukin 4
|
| 0051577 | Cytokine Production by Mononuclear Cells in Response to Mitogen Stimulation, Interleukin 5
|
| 0051581 | Cytokine Production by Mononuclear Cells in Response to Mitogen Stimulation, Interleukin 6
|
| 0051582 | Cytokine Production by Mononuclear Cells in Response to Mitogen Stimulation, Interleukin 8
|
| 0051578 | Cytokine Production by Mononuclear Cells in Response to Mitogen Stimulation, Interleukin 10
|
| 0051579 | Cytokine Production by Mononuclear Cells in Response to Mitogen Stimulation, Interleukin 13
|
| 0051566 | Cytokine Production by Mononuclear Cells in Response to Mitogen Stimulation, Monokines
|
| 0051558 | Cytokine Production by Mononuclear Cells in Response to Mitogen Stimulation, TH1 Cytokines
|
| 0051562 | Cytokine Production by Mononuclear Cells in Response to Mitogen Stimulation, TH2 Cytokines
|
| 0051583 | Cytokine Production by Mononuclear Cells in Response to Mitogen Stimulation, Tumor Necrosis Factor alpha
|
| 8290122 | Cytology, Anal
|
| 8209701 | Cytology, Body Cavity Fluid
|
| | Cytology, Body Cavity Fluid Collection
|
| 8209700 | Cytology, Breast Nipple Secretion
|
| 8280005 | Cytology, Bronchoalveolar Lavage, Malignancy
|
| | Cytology, Bronchoalveolar Lavage Specimen Collection
|
| 8209703 | Cytology, Cerebrospinal Fluid
|
| 8209713 | Cytology, Conjunctival Scraping
|
| | Cytology Consultation (Consultation, Cytopathology) |
| 8209706 | Cytology, Fine Needle Aspirate
|
| 2006889 | Cytology, Fine Needle Aspirate with Reflex to BRAF V600E Mutation Detection by Allele-Specific PCR, Fine Needle Aspirate
|
| | Cytology, Fine Needle Aspiration Collection
|
| 8209706 | Cytology FNA (Cytology, Fine Needle Aspirate) |
| 8209709 | Cytology, Gastrointestinal
|
| | Cytology, Gastrointestinal Specimen Collection
|
| 8209706 | Cytology Lymph Nodes (Cytology, Fine Needle Aspirate) |
| 8209710 | Cytology, Oral
|
| | Cytology, Oral Scraping or Brushing Specimen Collection
|
| 2000624 | Cytology, Pap Smear
|
| 8209702 | Cytology, Pulmonary
|
| | Cytology, Pulmonary Specimen Collection
|
| 8209706 | Cytology Salivary Glands (Cytology, Fine Needle Aspirate) |
| 8209712 | Cytology, Skin Scraping
|
| | Cytology, SurePath™ Liquid-Based Pap Test (AutoCyte PREP™ System) Specimen Collection
|
| 8100214 | Cytology, SurePath™ Liquid-Based Pap Test (AutoCyte PREP™ System) with Reflex to Human Papillomavirus (HPV) DNA Probe, High Risk
|
| 2000134 | Cytology, SurePath Liquid-Based Pap Test
|
| | Cytology, ThinPrep® Pap Test™ Specimen Collection
|
| 8100212 | Cytology, ThinPrep® Pap with Reflex to Human Papillomavirus (HPV) DNA Probe, High Risk
|
| 2000137 | Cytology, ThinPrep® Pap Test
|
| 8209706 | Cytology Thyroid Cysts (Cytology, Fine Needle Aspirate) |
| 8209714 | Cytology, Tzanck Smear
|
| 8209704 | Cytology, Urologic
|
| | Cytology, Urologic Specimen Collection
|
| 8209715 | Cytology, Vitreous Fluid
|
| 0050622 | Cytomegalovirus Antibodies, IgG and IgM
|
| 0050165 | Cytomegalovirus Antibody, IgG
|
| 0050553 | Cytomegalovirus Antibody, IgM
|
| 2004760 | Cytomegalovirus Antiviral Drug Resistance by Sequencing
|
| 0060040 | Cytomegalovirus by PCR
|
| 0060031 | Cytomegalovirus by PCR, Whole Blood or Bone Marrow
|
| 2003833 | Cytomegalovirus (CMV) by Immunohistochemistry
|
| 2003044 | Cytomegalovirus IgG Avidity (AviDx™), ELISA
|
| 0051813 | Cytomegalovirus, Quantitative PCR
|
| 2006966 | Cytomegalovirus, Quantitative PCR with Reflex to Drug Resistance Testing by Sequencing
|
| 0065004 | Cytomegalovirus Rapid Culture
|
| 2004760 | Cytomegalovirus Resistance (Cytomegalovirus Antiviral Drug Resistance by Sequencing) |
